Vanguard Asset Management
NUVB icon

Vanguard Asset Management’s Nuvation Bio NUVB Stock Holding History

Vanguard Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
183,438
+39,858
+28% +$195K ﹤0.01% 1861
2026
Q1 		$616K Buy
+143,580
New +$800K ﹤0.01% 1997

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Asset Management's NUVB Position: Q2 2026 in Review

Vanguard Asset Management increased its Nuvation Bio (NUVB) stake by 28% in Q2 2026, buying an estimated $195K and bringing the position to 183,438 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1861.

Vanguard Asset Management first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 221 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Vanguard Asset Management held 183,438 shares of Nuvation Bio worth $1.04M as of Q2 2026.
  • Vanguard Asset Management bought 39,858 Nuvation Bio shares in Q2 2026, an estimated $195K.
  • Nuvation Bio made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1861 holding.
  • Vanguard Asset Management first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 221 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.